Jounce Therapeutics Price History
JNCEDelisted Stock | USD 1.88 0.00 0.00% |
If you're considering investing in Jounce Stock, it is important to understand the factors that can impact its price. As of today, the current price of Jounce Therapeutics stands at 1.88, as last reported on the 17th of April 2024, with the highest price reaching 1.88 and the lowest price hitting 1.88 during the day. We have found four technical indicators for Jounce Therapeutics, which you can use to evaluate the volatility of the firm. Please check out Jounce Therapeutics' Day Median Price of 1.88, day typical price of 1.88, and Rate Of Daily Change of 1.0 to validate if the risk estimate we provide is consistent with the expected return of 0.0%.
Jounce Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
Jounce |
Sharpe Ratio = 0.0
Best Portfolio | Best Equity | |||
Good Returns | ||||
Average Returns | ||||
Small Returns | ||||
Cash | Small Risk | Average Risk | High Risk | Huge Risk |
JNCE |
Based on monthly moving average Jounce Therapeutics is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Jounce Therapeutics by adding Jounce Therapeutics to a well-diversified portfolio.
Jounce Therapeutics Stock Price History Chart
There are several ways to analyze Jounce Stock price data. The simplest method is using a basic Jounce candlestick price chart, which shows Jounce Therapeutics price history and the buying and selling dynamics of a specified period. Many traders also use subjective judgment to their trading calls, avoiding the need to trade based on technical analysis.
Jounce Stock Price History Data
Open | High | Low | Close | Volume | ||
04/17/2024 | 1.88 | 1.88 | 1.88 | 1.88 | ||
05/05/2023 | 1.88 | 1.88 | 1.88 | 1.88 | 1.00 | |
05/04/2023 | 1.88 | 1.88 | 1.88 | 1.88 | 1.00 | |
05/03/2023 | 1.92 | 1.93 | 1.88 | 1.88 | 11,589,391 | |
05/02/2023 | 1.91 | 1.93 | 1.91 | 1.93 | 2,313,702 | |
05/01/2023 | 1.93 | 1.94 | 1.91 | 1.92 | 1,909,704 | |
04/28/2023 | 1.93 | 1.95 | 1.92 | 1.93 | 628,615 | |
04/27/2023 | 1.93 | 1.95 | 1.91 | 1.94 | 793,994 | |
04/26/2023 | 1.94 | 1.95 | 1.91 | 1.93 | 1,095,113 | |
04/25/2023 | 1.93 | 1.96 | 1.93 | 1.93 | 874,864 | |
04/24/2023 | 1.91 | 1.92 | 1.90 | 1.90 | 242,816 | |
04/21/2023 | 1.90 | 1.92 | 1.90 | 1.91 | 395,689 | |
04/20/2023 | 1.90 | 1.92 | 1.90 | 1.91 | 442,193 | |
04/19/2023 | 1.91 | 1.92 | 1.90 | 1.90 | 385,520 | |
04/18/2023 | 1.92 | 1.94 | 1.90 | 1.90 | 567,643 | |
04/17/2023 | 1.90 | 1.98 | 1.90 | 1.92 | 982,300 | |
04/14/2023 | 1.93 | 1.93 | 1.89 | 1.92 | 830,200 | |
04/13/2023 | 1.87 | 1.94 | 1.87 | 1.92 | 769,510 | |
04/12/2023 | 1.87 | 1.90 | 1.86 | 1.89 | 1,616,142 | |
04/11/2023 | 1.87 | 1.89 | 1.86 | 1.87 | 629,700 | |
04/10/2023 | 1.87 | 1.88 | 1.86 | 1.87 | 1,107,234 | |
04/06/2023 | 1.88 | 1.90 | 1.86 | 1.89 | 691,868 | |
04/05/2023 | 1.87 | 1.90 | 1.86 | 1.90 | 2,184,401 | |
04/04/2023 | 1.85 | 1.88 | 1.84 | 1.87 | 1,429,858 | |
04/03/2023 | 1.85 | 1.86 | 1.84 | 1.85 | 1,228,197 | |
03/31/2023 | 1.85 | 1.86 | 1.84 | 1.85 | 1,040,375 | |
03/30/2023 | 1.85 | 1.87 | 1.83 | 1.85 | 5,371,312 | |
03/29/2023 | 1.84 | 1.86 | 1.84 | 1.85 | 3,350,982 | |
03/28/2023 | 1.83 | 1.85 | 1.83 | 1.84 | 11,195,105 | |
03/27/2023 | 1.87 | 1.90 | 1.81 | 1.83 | 15,863,597 | |
03/24/2023 | 1.50 | 1.52 | 1.46 | 1.51 | 907,418 | |
03/23/2023 | 1.52 | 1.54 | 1.48 | 1.52 | 1,288,352 | |
03/22/2023 | 1.59 | 1.60 | 1.45 | 1.48 | 1,561,458 | |
03/21/2023 | 1.67 | 1.69 | 1.56 | 1.59 | 1,132,176 | |
03/20/2023 | 1.65 | 1.72 | 1.61 | 1.67 | 2,109,647 | |
03/17/2023 | 1.55 | 1.64 | 1.53 | 1.61 | 3,115,055 | |
03/16/2023 | 1.43 | 1.62 | 1.40 | 1.56 | 4,268,418 | |
03/15/2023 | 1.46 | 1.64 | 1.43 | 1.49 | 29,099,397 | |
03/14/2023 | 1.02 | 1.09 | 0.99 | 1.06 | 448,821 | |
03/13/2023 | 0.95 | 1.01 | 0.94 | 1.00 | 667,300 | |
03/10/2023 | 1.00 | 1.04 | 0.90 | 0.90 | 581,598 | |
03/09/2023 | 1.08 | 1.09 | 0.95 | 0.96 | 694,989 | |
03/08/2023 | 1.03 | 1.11 | 0.92 | 1.07 | 1,137,191 | |
03/07/2023 | 1.06 | 1.09 | 0.99 | 1.05 | 827,788 | |
03/06/2023 | 1.10 | 1.11 | 1.01 | 1.08 | 3,066,304 | |
03/03/2023 | 1.16 | 1.19 | 1.10 | 1.11 | 722,833 | |
03/02/2023 | 1.11 | 1.21 | 1.10 | 1.16 | 675,900 | |
03/01/2023 | 1.13 | 1.18 | 1.10 | 1.16 | 1,478,091 | |
02/28/2023 | 1.15 | 1.20 | 1.09 | 1.12 | 2,899,263 | |
02/27/2023 | 1.13 | 1.25 | 1.13 | 1.15 | 3,372,569 | |
02/24/2023 | 1.10 | 1.17 | 1.04 | 1.15 | 3,693,699 | |
02/23/2023 | 1.22 | 1.36 | 1.09 | 1.10 | 42,028,088 | |
02/22/2023 | 1.03 | 1.07 | 0.98 | 0.99 | 268,842 | |
02/21/2023 | 1.10 | 1.18 | 1.01 | 1.04 | 371,704 | |
02/17/2023 | 1.09 | 1.11 | 1.02 | 1.10 | 293,842 | |
02/16/2023 | 1.11 | 1.11 | 1.08 | 1.08 | 190,904 | |
02/15/2023 | 1.13 | 1.14 | 1.10 | 1.12 | 265,800 | |
02/14/2023 | 1.12 | 1.15 | 1.09 | 1.12 | 214,924 | |
02/13/2023 | 1.11 | 1.14 | 1.08 | 1.11 | 175,500 | |
02/10/2023 | 1.11 | 1.15 | 1.08 | 1.11 | 260,300 | |
02/09/2023 | 1.20 | 1.22 | 1.11 | 1.11 | 298,632 |
About Jounce Therapeutics Stock history
Jounce Therapeutics investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Jounce is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Jounce Therapeutics will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Jounce Therapeutics stock prices may prove useful in developing a viable investing in Jounce Therapeutics
Jounce Therapeutics, Inc., a clinical-stage immunotherapy company, develops therapies for the treatment of cancer. Jounce Therapeutics, Inc. was incorporated in 2012 and is headquartered in Cambridge, Massachusetts. Jounce Therapeutics operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 137 people.
Jounce Therapeutics Stock Technical Analysis
Jounce Therapeutics technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, delisted stock market cycles, or different charting patterns.
Did you try this?
Run Portfolio Analyzer Now
Portfolio AnalyzerPortfolio analysis module that provides access to portfolio diagnostics and optimization engine |
All Next | Launch Module |
Check out Risk vs Return Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in main economic indicators. Note that the Jounce Therapeutics information on this page should be used as a complementary analysis to other Jounce Therapeutics' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Dashboard module to portfolio dashboard that provides centralized access to all your investments.
Other Consideration for investing in Jounce Stock
If you are still planning to invest in Jounce Therapeutics check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Jounce Therapeutics' history and understand the potential risks before investing.
Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
Fundamental Analysis View fundamental data based on most recent published financial statements | |
AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years |